The action of stobadin, a new highly effective antioxidant, on glutama
tergic neurotransmission in normal and ischemic rat brain have been st
udied. The basal release of L-[C-14]glutamate from brain slices did no
t change in the presence of 100 mu M of stobadin, but the K+-stimulate
d Ca2+-dependent release of the amino acid was inhibited. An enhanced
Ca2+-independent release of exogenous glutamate was observed in ischem
ic brain slices, though the K+-stimulated exocytosis of L-[C-14]glutam
ate was diminished to 58,4% of control and 74,5% of control in ischemi
c brain cortex and hyppocampus, respectively. The rate of exogenous gl
utamate uptake into ischemic brain synaptosomes tends to decrease in t
he presence of 1-100 mu M stobadin, but no reliable changes could be r
egistered as compared with control. The Na+/Ca2+-antiporter was not af
fected by stobadin in both normal and ischemic brain synaptosomes. It
was concluded that stobadin has no essential action on the studied sys
tems after 15-min ischemia. However, its action may be more effective
during a reperfusion period when its protective properties are the hig
hest.